FierceBiotech 9 déc. 2025 Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Endpoints News 8 déc. 2025 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive 8 déc. 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 26 nov. 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3